Effects of lipocalin-2 on brain endothelial adhesion and permeability

PLoS One. 2019 Jul 3;14(7):e0218965. doi: 10.1371/journal.pone.0218965. eCollection 2019.

Abstract

Lipocalin-2 (LCN2) is a stress protein, and can be hyper-produced by many kinds of cells after exposure to injury or disease conditions. In this study, we asked whether LCN2 may play a protective role in cerebral endothelium. After focal cerebral ischemia in rats, plasma levels of LCN2 were significantly elevated at 6, 12, and 24 hrs, and persisted until 3 days post-stroke. To assess the vascular mechanisms of LCN2, we used brain endothelial cell cultures to investigate its effects on neutrophil adhesion and endothelial barrier integrity. LCN2 did not affect neutrophil adhesion to endothelial cells either under normal conditions or after TNFα stimulation. TNFα significantly increased endothelial permeability, and LCN2 rescued endothelial permeability. Concomitantly, LCN2 restored the membrane distribution of the tight junction protein ZO-1 and the adherens junction protein VE-cadherin. Our findings suggest that elevated LCN2 in the blood after ischemic stroke might affect endothelial function, in part by reducing damage to endothelial junctional proteins and maintain blood-brain barrier integrity.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adherens Junctions / drug effects
  • Animals
  • Astrocytes / drug effects
  • Blood-Brain Barrier / drug effects
  • Brain / drug effects*
  • Brain / physiology
  • Cerebral Infarction / blood*
  • Cerebral Infarction / physiopathology
  • Disease Models, Animal
  • Endothelial Cells / drug effects
  • Humans
  • Lipocalin-2 / blood*
  • Permeability / drug effects
  • Rats
  • Stroke / blood*
  • Stroke / physiopathology
  • Tumor Necrosis Factor-alpha / blood
  • Zonula Occludens-1 Protein / blood

Substances

  • Lipocalin-2
  • Tjp1 protein, rat
  • Tumor Necrosis Factor-alpha
  • Zonula Occludens-1 Protein

Grants and funding

This study is supported by AHA, NIH, and the Rappaport Foundation.